Relypsa Inc (NASDAQ:RLYP)

Data as of Jan 23
 -0.02 / -0.05%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Relypsa, Inc. operates as a clinical-stage pharmaceutical company focused on the development and commercialization of non absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases. Its products include patiromer, a non-absorbed for the treatment of hyperkalemia and RLY6002, polymer drug discovery technology. The company was founded on October 29, 2007 and is headquartered in Redwood City, CA.

Contact Information

Relypsa, Inc.
700 Saginaw Drive
Redwood City California 94063
P:(650) 421-9500
Investor Relations:
(650) 421-9504



Other institutional49.49%
Individual stakeholders41.87%
Mutual fund holders20.92%

Top Executives

John A. OrwinPresident, Chief Executive Officer & Director
Wilhelm StahlSenior Vice President-Pharmaceutical Operations
Kristine McClintock BallChief Financial Officer & Senior Vice President
Lance BermanChief Medical Officer & Senior Vice President
Stephen D. HarrisonChief Scientific Officer & Senior Vice President

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.